The drug price short

Corporate villains are sometimes behind sudden increases in drug prices, but these unwanted surprises are often the result of a complicated and opaque healthcare system. The FT's David Crow joins Cardiff Garcia and Mary Childs to discuss in this snack-sized episode of the weekly podcast. Visit FT.com/Alphachat for show notes and links.

iTunes Stitcher audioBoom SoundCloud Overcast RSS


Copyright The Financial Times Limited 2017. All rights reserved. You may share using our article tools. Please don't copy articles from FT.com and redistribute by email or post to the web.